Ayala Pharmaceuticals
Clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies. Learn more
Launch date
Employees
Market cap
€774k
Enterprise valuation
€4m (Public information from Sep 2024)
Share price
$0.10105 ADXS
Rehovot Center District (HQ)
Authorizing premium user...